Skip to main content
. 2019 Oct 7;7:e7816. doi: 10.7717/peerj.7816

Figure 4. Survival analysis of CELSR3 expression in terms of relapse-free survival (RFS).

Figure 4

The RFS values were analyzed in regards to the mRNA expression level of CELSR3 in all tumors and subgroups of HCC patients. RFS analysis of (A) all tumors, (B) age < 60 years, (C) age ≥ 60 years, (D) male, (E) G1 + G2 stage, (F) stage I/II, (G) T1 stage, (H) N1Nx stage, (I) M0 stage, and (J) R0 stage. RFS, relapse-free survival.